Sep 7, 2025, 13:37
Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
RPTH Journal shared on LinkedIn:
”ECMO is life-saving technology!
What is better for patient outcomes? This review compares low dose vs standard unfractionated heparin on patient morbidity and mortality.”
Read the full article here.
Article: Mortality and Complications in Low-Dose versus Standard-Dose Unfractionated Heparin Anticoagulation for Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Authors: Wincy Wing-Sze Ng, Rex Wan-Hin Hui, Ka-Chun Leung, Pauline Yeung Ng, Chun-Wai Ngai, Simon Wai-Ching Sin, Chun-Fung Sin
Stay updated on the latest scientific advances in the field of coagulation with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 6, 2025, 06:34Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California